Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule

Videtic, 2017, Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline, Pract Radiat Oncol, 7, 295, 10.1016/j.prro.2017.04.014

Dalwadi, 2017, Outcomes in elderly stage I non-small cell lung cancer in the SBRT era: A SEER analysis

Fakiris, 2009, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study, Int J Radiat Oncol Biol Phys, 75, 677, 10.1016/j.ijrobp.2008.11.042

Bissonnette, 2009, Cone-beam computed tomographic image guidance for lung cancer radiation therapy, Int J Radiat Oncol Biol Phys, 73, 927, 10.1016/j.ijrobp.2008.08.059

Bradley, 2006, Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer, Radiother Oncol, 81, 264, 10.1016/j.radonc.2006.10.009

Carlson, 2011, Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia, Int J Radiat Oncol Biol Phys, 79, 1188, 10.1016/j.ijrobp.2010.10.007

Zhang, 2011, Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage I non-small cell lung cancer? A meta-analysis, Int J Radiat Oncol Biol Phys, 81, e305, 10.1016/j.ijrobp.2011.04.034

Stahl, 2016, The effect of biologically effective dose and radiation treatment schedule on overall survival in stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 96, 1011, 10.1016/j.ijrobp.2016.08.033

Alite, 2016, Local control dependence on consecutive versus nonconsecutive fractionation in lung stereotactic body radiation therapy, Radiother Oncol, 121, 9, 10.1016/j.radonc.2016.07.026

Bradley, 2010, Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The pattern of failure is distant, Int J Radiat Oncol Biol Phys, 77, 1146, 10.1016/j.ijrobp.2009.06.017

Videtic, 2010, Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: Excellent local control, Int J Radiat Oncol Biol Phys, 77, 344, 10.1016/j.ijrobp.2009.05.004

Latifi, 2014, Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm, Int J Radiat Oncol Biol Phys, 88, 1108, 10.1016/j.ijrobp.2013.12.047

Meyers

Contal, 1999, An application of changepoint methods in studying the effect of age on survival in breast cancer, Comput Stat Data Anal, 30, 253, 10.1016/S0167-9473(98)00096-6

Grills, 2012, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy, J Thorac Oncol, 7, 1382, 10.1097/JTO.0b013e318260e00d

Chi, 2010, Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications, Radiother Oncol, 94, 1, 10.1016/j.radonc.2009.12.008

Dunlap, 2010, Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT), J Thorac Cardiovasc Surg, 140, 583, 10.1016/j.jtcvs.2010.01.046

Horne, 2013, Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy, Radiat Oncol, 3, 1

Ochiai, 2016, The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung, J Radiat Res, 57, 555, 10.1093/jrr/rrw060

Brown, 2014, The tumor radiobiology of SRS and SBRT: Are more than 5 Rs involved?, Int J Radiat Oncol Biol Phys, 88, 54, 10.1016/j.ijrobp.2013.07.022

Shibamoto, 2012, Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: A multicenter study, Cancer, 118, 2078, 10.1002/cncr.26470

Shibamoto, 2015, Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small cell lung cancer: Five-year mature results, J Thorac Oncol, 10, 960, 10.1097/JTO.0000000000000525

Lischalk, 2016, Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC), J Radiat Oncol, 5, 379, 10.1007/s13566-016-0273-4

Brown, 2012, Dose escalation, not “new biology”, can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 85, 1159, 10.1016/j.ijrobp.2012.11.003

Song, 2015, Indirect tumor cell death after high-dose hypofractionated irradiation: Implications for stereotactic body radiation therapy and stereotactic radiation surgery, Int J Radiat Oncol Biol Phys, 93, 166, 10.1016/j.ijrobp.2015.05.016

Mehta, 2012, Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control, Pract Radiat Oncol, 2, 288, 10.1016/j.prro.2011.10.004

Lugade, 2005, Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor, J Immunol, 174, 7516, 10.4049/jimmunol.174.12.7516

Ohri, 2012, Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the Elekta collaborative lung research group, Int J Radiat Oncol Biol Phys, 84, e379, 10.1016/j.ijrobp.2012.04.040

Liu, 2017, Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models, Radiother Oncol, 122, 286, 10.1016/j.radonc.2016.11.006

Garau, 2017, Radiobiology of stereotactic body radiation therapy (SBRT), Rep Pract Oncol Radiother, 22, 86, 10.1016/j.rpor.2017.02.010

King, 2012, Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer, Int J Radiat Oncol Biol Phys, 82, 877, 10.1016/j.ijrobp.2010.11.054